NewsAccent Microcell Discloses Delay in Unit-III Trial Run and Commercial Production at Nayka, KhedaAccent Microcell Discloses Delay in Unit-III Trial Run and Commercial Production at Nayka, Kheda
Accent Microcell Limited has informed the National Stock Exchange of a delay in the trial run and commercial production schedule for its Unit-III facility at Nayka, District Kheda, citing two consecutive abnormal monsoon seasons and challenges in obtaining regulatory approvals. Key pending clearances include environment clearance and power transmission line approval in coordination with the R&B Department and applicable DISCOM. The company's management has stated it is actively engaging with authorities to secure approvals and commence operations at the earliest, though no revised timeline has been specified.
*this image is generated using AI for illustrative purposes only.
Accent Microcell Limited has formally notified the National Stock Exchange of India Limited of a delay in the scheduled implementation of trial run and commercial production at its Unit-III facility, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation, dated 13.05.2026, outlines the external circumstances that have caused the timeline to deviate from that stated in the company's Draft Red Herring Prospectus (DRHP).
Reasons Behind the Delay
Accent Microcell has cited two primary factors responsible for the delay at its Unit-III plant located at Nayka, District Kheda:
- Continuous two abnormal monsoon seasons, which disrupted construction and operational timelines at the facility.
- Unexpected challenges in liaising activities required to obtain various regulatory approvals from the concerned authorities.
These external circumstances collectively pushed the implementation schedule beyond the timelines originally communicated in the DRHP.
Pending Regulatory Approvals for Unit-III
The company has disclosed the current status of approvals that remain outstanding for Unit-III. The following key clearances are yet to be received:
| Pending Approval: | Details |
|---|---|
| Environment Clearance: | Awaited from relevant environmental authority |
| Power Transmission Line Approval: | Pending in coordination with R&B Department and applicable DISCOM |
Accent Microcell has stated that it is in continuous coordination with the relevant authorities to ensure these approvals are received at the earliest possible date.
Management's Position
The company's management has conveyed that it is striving continuously to commence the trial run and commercial production at Unit-III upon receiving the requisite approvals. No revised timeline or specific date for the commencement of operations has been disclosed in the intimation.
The disclosure was signed by Hiral Gajera, Company Secretary and Compliance Officer (M.No.: A48107), on behalf of Accent Microcell Limited. The company currently operates Unit-1 at Pirana Plant, Ahmedabad, and Unit-2 at Dahej SEZ, Bharuch, in Gujarat.
Historical Stock Returns for Accent Microcell
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.98% | +6.06% | +11.25% | +39.61% | +96.43% | +50.22% |
How might the continued delay in Unit-III's commissioning impact Accent Microcell's revenue projections and capacity expansion targets outlined in its DRHP?
What is the typical timeline for obtaining Environment Clearance in Gujarat's chemical/pharmaceutical sector, and could further monsoon seasons create additional construction setbacks?
How does the Unit-III delay affect Accent Microcell's competitive positioning against peers who may be expanding production capacity in the excipients market?
19
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
